immunotherapy
209 проекта
HEИндивидуална стипендия2025–2027Италия
iINGUT · immunotherapy on an INtegrated GUt microbiome and Tumor on-chip.
2 партньори
HEДокторантска мрежа2025–2029Германия
T-RAFIC · Training network for tracking and controlling therapeutic immune cells in cancer
28 партньори · 9 държави
HEИндивидуална стипендия2025–2027Испания
SMART-NHL · Studying the Microenvironment And Related Targets in Non-Hodgkin's Lymphoma
HEИндивидуална стипендия2025–2026Португалия
MultiTheranostic · Theranostic magnetic nano-based codelivery system for boosting cancer immunotherapy
2 партньори · 2 държави
HEИндивидуална стипендия2025–2027Швеция
MAPiT · Dissolving microneedle array patch-based psoriatic immunotherapy using nanoparticles
2 партньори
HEИндивидуална стипендия2025–2027Германия
UBImmune · Identification of novel therapeutic approaches to target the immune checkpoint protein B7H3
HEИндивидуална стипендия2025–2027Испания
DEXTER · Development of EXtracellular-based artificial bio-nanoparticles: a novel Targeted vector with high potential in cancer ThERapy
HEИндивидуална стипендия2025–2027Испания
CARLY · Development and characterization of a novel CAR T-cell therapy for NHL
2 партньори
HEИндивидуална стипендия2025–2027Белгия
noCOLDmore · Reprogramming eNdOthelial cells in immune-COLD tuMORs
2 партньори · 2 държави
HEИндивидуална стипендия2025–2027Белгия
DETECTIVE · DEmystifying Targets in Endothelial Cells for anti-Tumor Immunity improVEments
HEДокторантска мрежа2024–2028Нидерландия
Mac4Me · Macrophage Targets for Metastatic Treatment
26 партньори · 13 държави
HEДокторантска мрежа2024–2028Нидерландия
MIRACLE · Integrated multi-angle research and training network to eradicate leukemia minimal residual disease
22 партньори · 8 държави
HEИндивидуална стипендия2024–2026Нидерландия
SupraCODE · Spatial control of antigen-encoded supramolecular copolymers for robust T-cell activation against cancer
HEИндивидуална стипендия2024–2026Франция
HICoNK · Explore the role of NK cells in post-treatment control of HIV-1 infection: impact of genetic background and early treatment initiation
HEИндивидуална стипендия2024–2027Нидерландия
BEAT B-cell Lymphoma · Biomarkers of Effective CART19 Assessed in the Tissue Microenvironment
2 партньори · 2 държави
HEИндивидуална стипендия2024–2027Германия
MetaboTract · Improving cellular cancer immunotherapy using chemotactic metabolite receptors
HEИндивидуална стипендия2024–2025Испания
NIR-NanoCAR · Near-Infrared Photothermal Nano-CAR Immunotherapy mediated by engineered exosomes targeted to pancreatic cancer with mutated KRAS
2 партньори · 2 държави
HEИндивидуална стипендия2024–2025Франция
NanoImmunoRT · Synergizing enhanced radiotherapy with tumor-associated macrophages-targeted immunotherapy in glioblastoma with multimodal therapeutic nanoparticles
HEИндивидуална стипендия2024–2027Австрия
immunoMet · Deciphering immune evasion mechanisms of metastatic cancer cells using CRISPRa-inducible reporters
HEИндивидуална стипендия2024–2026Люксембург
INCEPTOR · Investigate the mode of action ofInvestigate the mode of action of beta-carboline derivative Harmine on increasing MHC-I expression and potentiating the Immune Checkpoint Blockade cancer immunotherapy
HEИндивидуална стипендия2024–2026Швеция
BiorthoCat-Immuno · Biorthogonal Catalytic Scaffold for in situ Personalized Cancer Chemo-Immunotherapy
HEИндивидуална стипендия2023–2025Франция
TABANK · Targeting B cell Activation driven by Natural Killer cells
HEИндивидуална стипендия2023–2026Белгия
IMEIV · Effect of insulin and feed/fast cycle on vaccine efficacy and safety.
HEИндивидуална стипендия2023–2025Ирландия